PURPOSE: To determine whether the sustained intravitreous delivery of CNTF modulates cortical response thresholds to electrical retinal stimulation in the RCS rat model of retinal degeneration. METHODS: Animals were assigned to four groups: untreated, nonsurgical control and infusion groups of 10 ng/d CNTF, 1 ng/d CNTF, and PBS vehicle control. Thresholds for electrically evoked cortical potentials (EECPs) were recorded in response to transcorneal electrical stimulation of the retina at p30 and again at p60, after a three-week infusion. RESULTS: As the retina degenerated over time, EECP thresholds in response to electrical retinal stimulation increased. Eyes treated with 10 ng/d CNTF demonstrated significantly greater retinal sensitivity to electrical stimulation when compared with all other groups. In addition, eyes treated with 1 ng/d CNTF demonstrated significantly greater retinal sensitivity than both PBS-treated and untreated control groups. CONCLUSIONS: Retinal sensitivity to electrical stimulation was preserved in animals treated with chronic intravitreous infusion of CNTF. These data suggest that CNTF-mediated retinal neuroprotection may be a novel therapy that can lower stimulus thresholds in patients about to undergo retinal prosthesis implantation. Furthermore, it may maintain the long-term efficacy of these devices in patients.
PURPOSE: To determine whether the sustained intravitreous delivery of CNTF modulates cortical response thresholds to electrical retinal stimulation in the RCS rat model of retinal degeneration. METHODS: Animals were assigned to four groups: untreated, nonsurgical control and infusion groups of 10 ng/d CNTF, 1 ng/d CNTF, and PBS vehicle control. Thresholds for electrically evoked cortical potentials (EECPs) were recorded in response to transcorneal electrical stimulation of the retina at p30 and again at p60, after a three-week infusion. RESULTS: As the retina degenerated over time, EECP thresholds in response to electrical retinal stimulation increased. Eyes treated with 10 ng/d CNTF demonstrated significantly greater retinal sensitivity to electrical stimulation when compared with all other groups. In addition, eyes treated with 1 ng/d CNTF demonstrated significantly greater retinal sensitivity than both PBS-treated and untreated control groups. CONCLUSIONS: Retinal sensitivity to electrical stimulation was preserved in animals treated with chronic intravitreous infusion of CNTF. These data suggest that CNTF-mediated retinal neuroprotection may be a novel therapy that can lower stimulus thresholds in patients about to undergo retinal prosthesis implantation. Furthermore, it may maintain the long-term efficacy of these devices in patients.
Authors: M Frasson; S Picaud; T Léveillard; M Simonutti; S Mohand-Said; H Dreyfus; D Hicks; J Sabel Journal: Invest Ophthalmol Vis Sci Date: 1999-10 Impact factor: 4.799
Authors: Paul A Sieving; Rafael C Caruso; Weng Tao; Hanna R Coleman; Darby J S Thompson; Keri R Fullmer; Ronald A Bush Journal: Proc Natl Acad Sci U S A Date: 2006-02-27 Impact factor: 11.205
Authors: Machelle T Pardue; Michael J Phillips; Hang Yin; Brian D Sippy; Sarah Webb-Wood; Alan Y Chow; Sherry L Ball Journal: Invest Ophthalmol Vis Sci Date: 2005-02 Impact factor: 4.799
Authors: Kun Do Rhee; Alberto Ruiz; Jacque L Duncan; William W Hauswirth; Matthew M Lavail; Dean Bok; Xian-Jie Yang Journal: Invest Ophthalmol Vis Sci Date: 2007-03 Impact factor: 4.799
Authors: Karl E Kador; Shawn P Grogan; Erik W Dorthé; Praseeda Venugopalan; Monisha F Malek; Jeffrey L Goldberg; Darryl D D'lima Journal: Tissue Eng Part A Date: 2016-01-27 Impact factor: 3.845
Authors: T Röck; A Schatz; L Naycheva; M Gosheva; J Pach; B Wilhelm; T Peters; K U Bartz-Schmidt; E Zrenner; G Willmann; F Gekeler Journal: Ophthalmologe Date: 2013-01 Impact factor: 1.059
Authors: E L West; R A Pearson; Y Duran; A Gonzalez-Cordero; R E MacLaren; A J Smith; J C Sowden; R R Ali Journal: Cell Transplant Date: 2012-02-02 Impact factor: 4.064
Authors: Jayashree N Sahni; Martina Angi; Cristina Irigoyen; Francesco Semeraro; Mario R Romano; Francesco Parmeggiani Journal: Curr Genomics Date: 2011-06 Impact factor: 2.236
Authors: Christine Haselier; Sonia Biswas; Sarah Rösch; Gabriele Thumann; Frank Müller; Peter Walter Journal: PLoS One Date: 2017-12-27 Impact factor: 3.240